Your browser doesn't support javascript.
loading
Chromosomal rearrangement-A rare cause of complement factor I associated atypical haemolytic uraemic syndrome.
Gleeson, Patrick J; Wilson, Valerie; Cox, Thomas E; Sharma, Seema D; Smith-Jackson, Kate; Strain, Lisa; Lappin, David; McHale, Teresa; Kavanagh, David; Goodship, Timothy H J.
Afiliação
  • Gleeson PJ; Departments of Nephrology and Histopathology, University Hospital Galway, Galway, Ireland.
  • Wilson V; Northern Molecular Genetics Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Cox TE; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
  • Sharma SD; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
  • Smith-Jackson K; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
  • Strain L; Northern Molecular Genetics Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Lappin D; Departments of Nephrology and Histopathology, University Hospital Galway, Galway, Ireland.
  • McHale T; Departments of Nephrology and Histopathology, University Hospital Galway, Galway, Ireland.
  • Kavanagh D; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
  • Goodship TH; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK. Electronic address: t.h.j.goodship@ncl.ac.uk.
Immunobiology ; 221(10): 1124-30, 2016 10.
Article em En | MEDLINE | ID: mdl-27268256
Chromosomal rearrangements affecting the genes encoding complement factor H and the factor H related proteins have been described in aHUS patients. To date such disorders have not been described in other aHUS associated genes. We describe here a heterozygous 875,324bp deletion encompassing the gene (CFI) encoding complement factor I and ten other genes. The index case presented with aHUS and did not recover renal function. No abnormalities were detected on Sanger sequencing of CFI but a low factor I level led to a multiplex ligation-dependent probe amplification assay being undertaken. This showed a complete heterozygous deletion of CFI. The extent of the deletion and the breakpoint was defined. In the Newcastle aHUS cohort we have identified and report here 32 different CFI variants in 56 patients but to date this is the only deletion that we have identified. This finding although rare does suggest that screening for chromosomal rearrangements affecting CFI should be undertaken in all aHUS patients particularly if the factor I level is unexplainably low.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Translocação Genética / Fator I do Complemento / Predisposição Genética para Doença / Síndrome Hemolítico-Urêmica Atípica Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Translocação Genética / Fator I do Complemento / Predisposição Genética para Doença / Síndrome Hemolítico-Urêmica Atípica Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article